Li Tang

Li Tang is a Professor at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the ME department. Their research is centered in the Laboratory of Biomaterials for Immunoengineering, where they explore innovative approaches in immunoengineering and biomaterials. Li Tang's work includes studies on CAR T cells, cytokine modulation, and nanoparticle drug delivery for enhanced cancer immunotherapy. They teach courses such as 'Concept to Early-Stage Drug and MedTech Products,' 'Immunoengineering,' and 'Next-Generation Biomaterials.' Their research has been published in prestigious journals including Nature, The Lancet Haematology, and Science Advances. Li Tang is also involved in supervising PhD students and contributing to doctoral program committees at EPFL.

Li Tang is an associate professor at École Polytechnique Fédérale de Lausanne, specializing in immunoengineering, immune metabolism, mechano-immunology, biomaterials, and cancer immunotherapy. Their research focuses on developing nanomedicine strategies to enhance cancer immunotherapy, including the design of size-specific drug-silica nanoconjugates and TCR-signaling-responsive nanoparticle drug delivery systems. Tang's work explores how metabolic reprogramming and mechanical cues influence T cell exhaustion and anti-tumor immunity, with applications in CAR T cell therapy and neoantigen vaccine delivery. By integrating smart chemistry and biomaterials, their research aims to improve the efficacy and specificity of immunotherapeutic approaches.